{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:56:56Z","timestamp":1790312216135,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.toxlet.2015.12.005","type":"journal-article","created":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T13:19:13Z","timestamp":1450876753000},"page":"7-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"special_numbering":"C","title":["Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting \u03b1-synuclein abnormalities in the substantia nigra"],"prefix":"10.1016","volume":"243","author":[{"given":"Yang","family":"Heng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Shuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Feng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-He","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nai-Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2015.12.005_bib0005","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/jnc.12343","article-title":"Probenecid potentiates MPTP\/MPP+ toxicity by interference with cellular energy metabolism","volume":"127","author":"Alvarez-Fischer","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0010","doi-asserted-by":"crossref","first-page":"e61700","DOI":"10.1371\/journal.pone.0061700","article-title":"Bee venom and its component apamin as neuroprotective agents in a Parkinson disease mouse model","volume":"8","author":"Alvarez-Fischer","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.toxlet.2015.12.005_bib0015","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S1474-4422(10)70213-1","article-title":"Are synucleinopathies prion-like disorders?","volume":"9","author":"Angot","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0020","doi-asserted-by":"crossref","first-page":"10558","DOI":"10.1523\/JNEUROSCI.1799-06.2006","article-title":"Alpha-synuclein expression modulates microglial activation phenotype","volume":"26","author":"Austin","year":"2006","journal-title":"J. Neurosci. Off. J. Soc. Neuroscie."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0025","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.tins.2009.05.009","article-title":"Air pollution: mechanisms of neuroinflammation and CNS disease","volume":"32","author":"Block","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neuroscience.2011.10.057","article-title":"Neurotoxin-based models of Parkinson\u2019s disease","volume":"211","author":"Bove","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.toxlet.2015.12.005_bib0035","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.toxlet.2015.12.005_bib0040","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbadis.2011.10.002","article-title":"Alpha-synuclein misfolding and Parkinson\u2019s disease","volume":"1822","author":"Breydo","year":"2012","journal-title":"Biochimica. Biophys. Acta"},{"key":"10.1016\/j.toxlet.2015.12.005_bib0045","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fncel.2014.00211","article-title":"Astrocytic modulation of blood brain barrier: perspectives on Parkinson\u2019s disease","volume":"8","author":"Cabezas","year":"2014","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0050","first-page":"345285","article-title":"Is Parkinson\u2019s disease truly a prion-like disorder? An appraisal of current evidence","author":"Chauhan","year":"2015","journal-title":"Neurol. Res. Int."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0055","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.bbrc.2007.02.163","article-title":"Oligomeric alpha-synuclein inhibits tubulin polymerization","volume":"356","author":"Chen","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0060","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00702-003-0005-y","article-title":"Protective effect of ginsenoside Rg1 on MPP+ -induced apoptosis in SHSY5Y cells","volume":"110","author":"Chen","year":"2003","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0065","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1745-7254.2005.00019.x","article-title":"Ginsenoside Rg1 reduces MPTP-induced substantia nigra neuron loss by suppressing oxidative stress","volume":"26","author":"Chen","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0070","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1073\/pnas.1218424110","article-title":"Large alpha-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking","volume":"110","author":"Choi","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.toxlet.2015.12.005_bib0075","first-page":"370526","article-title":"MMP-3 contributes to nigrostriatal dopaminergic neuronal loss, BBB damage, and neuroinflammation in an MPTP mouse model of Parkinson\u2019s disease","author":"Chung","year":"2013","journal-title":"Mediators Inflamm."},{"issue":"8","key":"10.1016\/j.toxlet.2015.12.005_bib0080","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S1474-4422(15)00006-X","article-title":"Targeting \u03b1-synuclein for treatment of Parkinson\u2019s disease: mechanistic and therapeutic considerations","volume":"14","author":"Dehay","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0085","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1073\/pnas.0903691106","article-title":"Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein","volume":"106","author":"Desplats","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.toxlet.2015.12.005_bib0090","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/glia.22437","article-title":"Toll-like receptor 4 is required for alpha-synuclein dependent activation of microglia and astroglia","volume":"61","author":"Fellner","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.toxlet.2015.12.005_bib0095","first-page":"436813","article-title":"Parkinson\u2019s disease and systemic inflammation","author":"Ferrari","year":"2011","journal-title":"Parkinson\u2019s Disease"},{"key":"10.1016\/j.toxlet.2015.12.005_bib0100","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0006-8993(88)91111-0","article-title":"An electron microscopic study of MPTP-induced inclusion bodies in an old monkey","volume":"448","author":"Forno","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0105","first-page":"4127","article-title":"Phosphorylated alpha-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson\u2019s disease","volume":"25","author":"Foulds","year":"2011","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0110","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0115","doi-asserted-by":"crossref","first-page":"7929","DOI":"10.1074\/jbc.C113.538249","article-title":"Evidence of native alpha-synuclein conformers in the human brain","volume":"289","author":"Gould","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0120","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","article-title":"Parkinson\u2019s disease: a dual-hit hypothesis","volume":"33","author":"Hawkes","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson\u2019s disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000431100","article-title":"Ginsenoside Rg1 Ameliorates Motor Function in an Animal Model of Parkinson\u2019s Disease","volume":"96","author":"Jiang","year":"2015","journal-title":"Pharmacology"},{"key":"10.1016\/j.toxlet.2015.12.005_bib0135","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.toxlet.2015.12.005_bib0140","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/ncomms2534","article-title":"Neuron-released oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia","volume":"4","author":"Kim","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0145","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00401-012-0964-x","article-title":"An antibody with high reactivity for disease-associated alpha-synuclein reveals extensive brain pathology","volume":"124","author":"Kovacs","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12031-007-0012-9","article-title":"Origins and effects of extracellular alpha-synuclein: implications in Parkinson\u2019s disease","volume":"34","author":"Lee","year":"2008","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0155","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1523\/JNEUROSCI.0692-05.2005","article-title":"Intravesicular localization and exocytosis of alpha-synuclein and its aggregates","volume":"25","author":"Lee","year":"2005","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0160","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","article-title":"Parkinson\u2019s disease","volume":"373","author":"Lees","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.toxlet.2015.12.005_bib0165","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s12035-012-8267-8","article-title":"Inflammation and alpha-synuclein\u2019s prion-like behavior in Parkinson\u2019s disease\u2014is there a link?","volume":"47","author":"Lema Tome","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0170","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.neuropharm.2006.10.001","article-title":"Neuroprotective effects of ginsenoside-Rg1 in primary nigral neurons against rotenone toxicity","volume":"52","author":"Leung","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.toxlet.2015.12.005_bib0175","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm1746","article-title":"Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation","volume":"14","author":"Li","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0180","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.neuint.2010.11.004","article-title":"Ginsenoside Rg1 protects against hydrogen peroxide-induced cell death in PC12 cells via inhibiting NF-kappaB activation","volume":"58","author":"Liu","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0185","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbr.2015.07.058","article-title":"Environment-contact administration of rotenone: A new rodent model of Parkinson\u2019s disease","volume":"294","author":"Liu","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0190","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.physbeh.2009.04.021","article-title":"Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson\u2019s disease","volume":"98","author":"Luchtman","year":"2009","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0195","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bbr.2011.09.033","volume":"226","author":"Luchtman","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0200","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.toxlet.2015.12.005_bib0205","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1385\/JMN:24:3:401","article-title":"Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (\u2212)-epigallocatechin-3-gallate","volume":"24","author":"Mandel","year":"2004","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0210","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.21751","article-title":"Glial reactions in Parkinson\u2019s disease","volume":"23","author":"McGeer","year":"2008","journal-title":"Mov. Disord. Offi. J. Mov. Disord. Soc."},{"issue":"Suppl. 2","key":"10.1016\/j.toxlet.2015.12.005_bib0215","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/j.parkreldis.2008.04.012","article-title":"Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol","volume":"14","author":"Meredith","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0220","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/ana.23687","article-title":"Meta-analysis of early nonmotor features and risk factors for Parkinson disease","volume":"72","author":"Noyce","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0225","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s11481-012-9363-2","article-title":"Neuroprotective effect of curcuminoids against inflammation-mediated dopaminergic neurodegeneration in the MPTP model of Parkinson\u2019s disease","volume":"7","author":"Ojha","year":"2012","journal-title":"J. Neuroimmune Pharmacol. Off. J. Soc. Neuroimmune Pharmacol."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0230","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/jnc.13060","article-title":"Extracellular alpha-synuclein alters synaptic transmission in brain neurons by perforating the neuronal plasma membrane","volume":"132","author":"Pacheco","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0235","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.etp.2012.09.001","article-title":"Toxicity of MPTP on neurotransmission in three mouse models of Parkinson\u2019s disease","volume":"65","author":"Pain","year":"2013","journal-title":"Exp. Toxicol. Pathol. Off. J. Ges. Toxikol. Pathol."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0240","doi-asserted-by":"crossref","first-page":"16895","DOI":"10.1074\/jbc.M800747200","article-title":"Phosphorylation at Ser-129 but not the phosphomimics S129E\/D inhibits the fibrillation of alpha-synuclein","volume":"283","author":"Paleologou","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0245","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0306-4522(01)00295-0","article-title":"Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP\/probenecid treatment","volume":"106","author":"Petroske","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.toxlet.2015.12.005_bib0250","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/glia.20467","article-title":"Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration","volume":"55","author":"Qin","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.toxlet.2015.12.005_bib0255","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.brainres.2004.06.030","article-title":"Ginsenosides Rb1 and Rg1 effects on mesencephalic dopaminergic cells stressed with glutamate","volume":"1021","author":"Radad","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0260","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12868-015-0192-0","article-title":"Exogenous alpha-synuclein induces toll-like receptor 4 dependent inflammatory responses in astrocytes","volume":"16","author":"Rannikko","year":"2015","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0265","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3390\/biom5020282","article-title":"Seeking a mechanism for the toxicity of oligomeric alpha-synuclein","volume":"5","author":"Roberts","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.toxlet.2015.12.005_bib0270","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1093\/brain\/awu057","article-title":"Accumulation of oligomer-prone alpha-synuclein exacerbates synaptic and neuronal degeneration in vivo","volume":"137","author":"Rockenstein","year":"2014","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0275","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1042\/AN20120066","article-title":"Neuroimmunological processes in Parkinson\u2019s disease and their relation to alpha-synuclein: microglia as the referee between neuronal processes and peripheral immunity","volume":"5","author":"Sanchez-Guajardo","year":"2013","journal-title":"ASN Neuro"},{"key":"10.1016\/j.toxlet.2015.12.005_bib0280","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neuroscience.2015.02.008","article-title":"The relation between alpha-synuclein and microglia in Parkinson\u2019s disease: recent developments","volume":"302","author":"Sanchez-Guajardo","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.toxlet.2015.12.005_bib0285","doi-asserted-by":"crossref","first-page":"S307","DOI":"10.1007\/s00415-011-6016-y","article-title":"Aetiopathogenesis of Parkinson\u2019s disease","volume":"258","author":"Schapira","year":"2011","journal-title":"J. Neurol."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0290","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12640-009-9061-x","article-title":"Progressive dopaminergic degeneration in the chronic MPTPp mouse model of Parkinson\u2019s disease","volume":"16","author":"Schintu","year":"2009","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0295","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-4328(01)00309-6","article-title":"Behavioral phenotyping of the MPTP mouse model of Parkinson\u2019s disease","volume":"125","author":"Sedelis","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0300","article-title":"Escin attenuates behavioral impairments, oxidative stress and inflammation in a chronic MPTP\/probenecid mouse model of Parkinsons disease","volume":"17","author":"Selvakumar","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0305","article-title":"Escin, a Novel Triterpene, Mitigates Chronic MPTP\/p-Induced Dopaminergic Toxicity by Attenuating Mitochondrial Dysfunction, Oxidative Stress, and Apoptosis","volume":"55","author":"Selvakumar","year":"2014","journal-title":"J. Mol. Neurosc."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0310","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.mehy.2015.02.004","volume":"84","author":"Sica","year":"2015","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.toxlet.2015.12.005_bib0315","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1097\/00001756-200107030-00028","article-title":"Expression of alpha-synuclein in a human glioma cell line and its up-regulation by interleukin-1beta","volume":"12","author":"Tanji","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.toxlet.2015.12.005_bib0320","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.neuint.2012.12.016","article-title":"Neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson\u2019s disease","volume":"62","author":"Taylor","year":"2013","journal-title":"Neurochem. Int."},{"issue":"42","key":"10.1016\/j.toxlet.2015.12.005_bib0325","article-title":"Protein phosphorylation in neurodegeneration: friend or foe?","volume":"7","author":"Tenreiro","year":"2014","journal-title":"Fron. Mol. Neurosci."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0330","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S1474-4422(11)70213-7","article-title":"Pathological roles of \u03b1-synuclein in neurological disorders","volume":"10","author":"Vekrellis","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0335","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4103\/0972-2327.144284","article-title":"Toxic species in amyloid disorders: oligomers or mature fibrils","volume":"18","author":"Verma","year":"2015","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0340","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1471-4159.2000.740721.x","article-title":"Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP","volume":"74","author":"Vila","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0345","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002566","article-title":"Phosphorylated alpha-synuclein in Parkinson\u2019s disease","volume":"4","author":"Wang","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0350","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020396","article-title":"The astrocyte: powerhouse and recycling center","author":"Weber","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0355","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.bjp.0707167","article-title":"Inflammation as a causative factor in the aetiology of Parkinson\u2019s disease","volume":"150","author":"Whitton","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0360","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In vivo demonstration that alpha-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.toxlet.2015.12.005_bib0365","doi-asserted-by":"crossref","first-page":"337","DOI":"10.5607\/en.2014.23.4.337","article-title":"Exploring myelin dysfunction in multiple system atrophy","volume":"23","author":"Wong","year":"2014","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0370","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1476-5381.2009.00361.x","article-title":"Ginsenoside Rg1 protects dopaminergic neurons in a rat model of Parkinson\u2019s disease through the IGF-I receptor signalling pathway","volume":"158","author":"Xu","year":"2009","journal-title":"B. J. Pharmacol."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0375","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jnc.13234","article-title":"The phosphorylation of alpha-synuclein: development and implication for the mechanism and therapy of the Parkinson\u2019s disease","volume":"135","author":"Xu","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0380","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/jnr.21931","article-title":"Iptakalim ameliorates MPP+-induced astrocyte mitochondrial dysfunction by increasing mitochondrial complex activity besides opening mitoK(ATP) channels","volume":"87","author":"Zhang","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.toxlet.2015.12.005_bib0385","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pbb.2014.03.028","article-title":"Neuroprotective effects of the andrographolide analogue AL-1 in the MPP\/MPTP-induced Parkinson\u2019s disease model in vitro and in mice Pharmacol","volume":"122C","author":"Zhang","year":"2014","journal-title":"Biochem Behav"}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427415301326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427415301326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T18:30:45Z","timestamp":1567449045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427415301326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":77,"alternative-id":["S0378427415301326"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2015.12.005","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting \u03b1-synuclein abnormalities in the substantia nigra","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2015.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}